3 unknown, 2 terminated, 1 suspended. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 3, Terminated 1 |
| Phase 3 | 2 | Suspended 1, Terminated 1 |
Follow Favrille: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma autologous immunoglobulin idiotype-KLH conjugate vaccine, sargramostim - Lymphoma | Phase 2 | Terminated | Favrille | 238 | 2004-09-01 | 2013-08-02 |
| Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma autologous immunoglobulin idiotype-KLH conjugate vaccine, rituximab, sargramostim - Lymphoma | Phase 2 | Unknown | Favrille | 56 | 2004-08-01 | 2014-01-10 |
| Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma autologous immunoglobulin idiotype-KLH conjugate vaccine, rituximab, sargramostim - Lymphoma | Phase 3 | Terminated | Favrille | 2004-07-01 | 2013-08-02 | |
| Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma Id-KLH - Non-Hodgkin's Lymphoma | Phase 2 | Unknown | Favrille | 90 | 2002-07-01 | 2009-09-30 |
| Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma FavId (Id-KLH) active immunotherapy - Lymphoma, Low-Grade | Phase 2 | Unknown | Favrille | 22 | 2001-03-01 | 2005-06-24 |
| GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma autologous immunoglobulin idiotype-KLH conjugate vaccine, cyclophosphamide, doxorubicin hydrochloride - Lymphoma | Phase 3 | Suspended | Favrille | 480 | 2013-12-18 |
Lymphoma (6) · Lymphoma, Follicular (3) · Lymphoma, Non-Hodgkin (2) · Lymphoma, Large B-Cell, Diffuse (1)
sargramostim (4) · Rituximab (3) · Immunotherapy, Active (2) · Antibodies, Monoclonal (1) · Biological Therapy (1) · Coal Tar (1) · Cyclophosphamide (1) · Doxorubicin (1) · Drug Therapy (1) · Immunization, Passive (1) · Methods (1) · Prednisone (1) · Vincristine (1)
United States (6)